接口广告
摩熵化学
数据开放平台 数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

有机化合物

中文名称 英文名称 CAS号 化学式
—— 5-{2-[2-(2-methoxyphenoxy)-ethylamino]-1-phenylthioethyl}-2-methylbenzenesulfonamide —— C24H28N2O4S2
—— 4-amino-6-chloro-2-(3-bromophenylmethylsulfonyl)-pyrimidine —— C11H9BrClN3O2S
—— 2-pyridin-3-yl-7-p-tolyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine —— C18H13N7
—— 5-{2-[2-(2-methoxyphenoxy)-ethylamino]-1-phenylsulfinylethyl}-2-methylbenzenesulfonamide —— C24H28N2O5S2
—— 2-thioureido-5,6-dihydro-s-triazolo[5,1-a]isoquinoline —— C11H11N5S
—— N-(5-chloro-3-(4-(2-chloro-5-(trifluoromethyl)phenyl)-5-cyano-6-oxo-1,6-dihydropyridin-2-yl)-2-hydroxybenzyl)-N-methyl-2-(3-pyridinyl)acetamide —— C28H19Cl2F3N4O3
—— α-[5-bromo-2-[(4-chlorophenyl)methoxy]phenyl]-4-(3-pyridinylcarbonyl)-1-piperazineethanol —— C25H25BrClN3O3
—— N-(p-benzoic acid)-3,4-dithiophenoylmaleimide —— C23H15NO4S2
—— N-[1-(3-isopropoxy-benzoyl)-6,7-dimethoxy-isoquinolin-4-ylmethyl]-nicotinamide —— C28H27N3O5
—— α-[5-bromo-2-[(4-chlorophenyl)methoxy]phenyl]-1-piperazineethanol —— C19H22BrClN2O2
—— N-(phenylacetyl)doxorubicin —— C35H35NO12
—— 3,4-dithiophenoylmaleimide-N-hexanoic acid —— C22H21NO4S2
—— N-succinimidyl 5-(doxorubicin-3'-N-yl)-5-oxopentanoate —— C36H38N2O16
—— Ac-Pro-Ala-Ser-Chg-Gln-Ser-Leu-OH —— C35H58N8O12
—— Ac-Ala-Ala-Ala-Dox —— C38H46N4O15
—— Ac-Lys(Fmoc)-Ala-Ser-Tyr-Gln-Ser-Leu-OH —— C52H69N9O15
—— Ac-Ala-Asn-Lys(Fmoc)-Ala-Ser-Tyr-Gln-Ser-Ser-Ser-Leu-OH —— C65H90N14O22
—— Ac-Orn(Fmoc)-Ala-Ser-Tyr-Gln-Ser-Leu-OH —— C51H67N9O15
—— Ac-Lys(Fmoc)-Tyr-Gln-Ser-Ser-Ser-Leu-OH —— C52H69N9O16
—— Ac-Orn(Fmoc)-Tyr-Gln-Ser-Ser-Ser-Leu-OH —— C51H67N9O16
—— [(S)-1-[1-(dimethylamino)ethyl]naphthyl-C(2),N][(1α,4α,5α(R))-4,5-bis(diphenylphosphino)-7-oxabicyclo[2.2.1]hept-2-ene-P(4),P(5)]platinum(II) tetrafluoroborate —— BF4*C44H42NOP2Pt
—— Ac-Ala-Asn-Lys(Fmoc)-Ala-Ser-Tyr-Gln-Ser-Ala-Ser-Leu-OH —— C65H90N14O21
—— Ac-Orn(Fmoc)-Ala-Ser-Tyr-D-Gln-Ser-Leu-OH —— C51H67N9O15
—— Ac-Lys(Fmoc)-Ala-Ser-Chg-Gln-Ser-Leu-OH —— C51H73N9O14
—— zinc nicotinate —— 2C6H4NO2*Zn
—— succinyl(OFm)-Hyp-Ala-Ser-Chg-Gln-Ser-Leu-OH —— C51H70N8O15
—— 5-(3-((3-(3-chloro-phenyl)-propyl)-(pyridine-3-carbonyl)-amino)-propyl)-thiophene-2-carboxylic acid methyl ester —— C24H25ClN2O3S
—— (2R)-2-[(5S)-3-(5-{2-fluoro-4-[(5R)-2-oxo-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-3-yl]phenyl}pyridin-2-yl)-4,5-dihydroisoxazol-5-yl]-2-hydroxyethyl nicotinoate —— C28H24FN7O6
—— Ac-Ala-Asn-Lys(Fmoc)-Ala-Ser-Tyr-Gln-Ser-Ser-Leu-OH —— C62H85N13O20
—— Ac-Pro-Ala-Ser-Chg-Gln-Ser-Leu-Dox —— C62H85N9O22
—— Ac-Hyp-Ala-Ser-Chg-Gln-Ser-Leu-Dox —— C62H85N9O23
—— N-{4-[4-(2-tert-butyl-6-cyclobutyl-pyrimidin-4-yl)-piperazin-1-yl]-butyl}-nicotinamide —— C26H38N6O
—— Ac-Hyp-Ala-Ser-Chg-Gln-Ser-Leu-OH —— C35H58N8O13
—— N,N-dibenzyloxycarbonylornithine —— C21H24N2O6
—— (S)-(-)-10,11-dihydro-10-nicotinoyloxy-5H-dibenz/b,f/azepine-5-carboxamide —— C21H17N3O3
—— [(1S)-1-carboxy-2-(1H-imidazol-5-yl)ethyl]azanium;pyridine-3-carboxylate —— 2C6H5NO2*C6H9N3O2
—— 4-[8-Chloro-3,7-dibromo-6,11-dihydro-5H-benzo[5,6]cyclo-hepta[1, 2-b]pyridin-11-yl]-1-(4-thiomorpholinylacetyl)piperidine S-oxide —— C25H28Br2ClN3O2S
—— N-tert-butyl-N'-phenyl-S-phenylisothiourea —— C17H20N2S
—— N-(4-(oxazolo[4,5-c]pyridin-2-yl)benzyl)nicotinamide —— C19H14N4O2
—— L-arginine nicotinate —— C6H5NO2*C6H14N4O2
—— silver nicotinate —— C6H4AgNO2
—— 2-(benzhydrylthio)propionamide —— C16H17NOS
—— 5-[3-hydroxy-3-(4-methoxyphenyl)propylsulfonyl]thiophene-2-sulfonamide —— C14H17NO6S3
—— N-decanoyl-3-piperidinecarboxylic acid —— C16H29NO3
—— (E)-2,5-dioxopyrrolidin-1-yl 1-(cyclooct-4-en-1-yloxy)-1-oxo-5,8,11,14-tetraoxa-2-azaheptadecan-17-oate —— C24H38N2O10
—— 1-(N-(6-(2-(2-sulfonatobenzaldehyde)hydrazono)nicotinyl))-6-(nicotinoyl) hexanediamine —— C25H28N6O5S
—— 2,8-dimethyl-N-(1-naphthyl)quinolin-4-amine —— C21H18N2
—— 2-(benzhydrylsulphinyl)propionamide —— C16H17NO2S
—— isoamylene oxide —— C10H18O
—— 13-benzenesulfonylhydrazone-doxorubicin hydrochloride —— C33H35N3O12S*ClH